Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
The Journal of Urology|July 22, 2008
Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinomaAkio Horiguchi, Tomohiko Asano, Takako Asano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasisAkio Horiguchi, Makoto Sumitomo, Junichi Asakuma, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2013
Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumorsKosuke Miyai, Keiichi Iwaya, Tomohiko Asano, et al.
Japanese Journal of Clinical Oncology|February 5, 2008
Decreased serum adiponectin levels in patients with metastatic renal cell carcinomaAkio Horiguchi, Keiichi Ito, Makoto Sumitomo, et al.
The Journal of Urology|June 17, 2008
Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cellsAkio Horiguchi, Tomohiko Asano, Takako Asano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 26, 2010
Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancerMakoto Sumitomo, Junichi Asakuma, Akinori Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathwayMakoto Sumitomo, Tomohiko Asano, Junichi Asakuma, et al.
Pageof 17